GlaxoSmithKline PLC (GSK), anglo-American drugs giant, has entered into an agreement to acquire Chinese urology and allergy treatments specialist Nanjing MeiRui Pharma Co., Ltd for around $70 million. Nanjing MeiRui Pharma Co. is a leading Chinese pharmaceutical business with a strong portfolio of urology and allergy products, including Prostat for benign prostatic hyperplasia and Sheniting for [...]